187 related articles for article (PubMed ID: 2407492)
1. Vascular haemodynamic effects of perindopril in essential hypertension.
Littler W
Drugs; 1990; 39 Suppl 1():43-8. PubMed ID: 2407492
[TBL] [Abstract][Full Text] [Related]
2. Experience with perindopril in normal volunteers.
Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
Clin Exp Hypertens A; 1989; 11 Suppl 2():507-19. PubMed ID: 2605800
[TBL] [Abstract][Full Text] [Related]
3. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
Harrap SB; Van der Merwe WM; Griffin SA; Macpherson F; Lever AF
Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Fogari R; Zoppi A; Lazzari P; Preti P; Mugellini A; Corradi L; Lusardi P
J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of perindopril: experimental pharmacology.
Barthelmebs M; Devissaguet M; Imbs JL
Clin Exp Hypertens A; 1989; 11 Suppl 2():471-86. PubMed ID: 2691126
[TBL] [Abstract][Full Text] [Related]
6. The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients.
Lees KR; Reid JL
Eur J Clin Pharmacol; 1987; 31(5):519-24. PubMed ID: 3030762
[TBL] [Abstract][Full Text] [Related]
7. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
[TBL] [Abstract][Full Text] [Related]
8. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
Brown CL; Backhouse CI; Grippat JC; Santoni JP
Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713
[TBL] [Abstract][Full Text] [Related]
9. [Antihypertensive effect of perindopril. Experimental pharmacology].
Barthelmebs M; Devissaguet M; Imbs JL
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
[TBL] [Abstract][Full Text] [Related]
10. Perindopril. A review of its pharmacokinetics and clinical pharmacology.
Macfadyen RJ; Lees KR; Reid JL
Drugs; 1990; 39 Suppl 1():49-63. PubMed ID: 2407493
[TBL] [Abstract][Full Text] [Related]
11. Experience with perindopril in normal volunteers.
Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
[TBL] [Abstract][Full Text] [Related]
12. Effect of perindopril on 24-hour blood pressure levels and hemodynamic responses to physical and mental stress in elderly hypertensive patients.
Kuwajima I; Fujisawa A; Mitani K; Suzuki Y; Kuramoto K
Clin Ther; 1994; 16(6):962-71. PubMed ID: 7697693
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of perindopril in essential hypertension.
Asmar RG; Pannier B; Laurent ST; Benetos A; Daou J; Safar M
J Hum Hypertens; 1990 Oct; 4 Suppl 4():35-43; discussion 44. PubMed ID: 2283652
[TBL] [Abstract][Full Text] [Related]
14. Vascular effects of perindopril: from experimental to clinical investigation.
Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
[TBL] [Abstract][Full Text] [Related]
15. [Peripheral hemodynamic and biological effects of perindopril in the healthy subject. Dose-effect relationship].
Richer C; Thuillez C; Desmichels D; Giudicelli JF
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):913-8. PubMed ID: 3026273
[TBL] [Abstract][Full Text] [Related]
16. Renal amylin binding in normotensive and hypertensive rats: effects of angiotensin converting enzyme inhibition with perindopril.
Cao Z; Wookey PJ; Wu LL; Voskuil M; van Geenen RC; Cooper ME
J Hypertens; 1997 Nov; 15(11):1245-52. PubMed ID: 9383173
[TBL] [Abstract][Full Text] [Related]
17. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
Lantelme P; Lo M; Luttenauer L; Sassard J
Am J Physiol; 1997 Nov; 273(5):R1793-9. PubMed ID: 9374825
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of perindopril.
Lees KR
J Hum Hypertens; 1990 Oct; 4 Suppl 4():7-8; discussion 9-11. PubMed ID: 2283658
[TBL] [Abstract][Full Text] [Related]
19. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.
Lees KR; Reid JL
Br J Clin Pharmacol; 1987 Feb; 23(2):159-64. PubMed ID: 3030387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
